Platz K - Search Results

1

First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation.

Kahl A, Bechstein WO, Platz K, Müller A, Berweck S, Venz S, Neuhaus P, Frei U. Kahl A, et al. Among authors: platz k. Transplant Proc. 1998 Mar;30(2):505-6. doi: 10.1016/s0041-1345(97)01377-8. Transplant Proc. 1998. PMID: 9532149 Clinical Trial. No abstract available.

2

Clinical use of the euglycemic hyperinsulinemic clamp for diagnosis of tacrolimus-induced insulin resistance after combined pancreas-kidney transplantation.

Berweck S, Kahl A, Bechstein W, Platz K, Müller U, Neuhaus P, Frei U. Berweck S, et al. Among authors: platz k. Transplant Proc. 1998 Aug;30(5):1944-5. doi: 10.1016/s0041-1345(98)00490-4. Transplant Proc. 1998. PMID: 9723345 No abstract available.

3

Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.

Mueller AR, Platz KP, Bechstein WO, Schattenfroh N, Stoltenburg-Didinger G, Blumhardt G, Christe W, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplantation. 1994 Jul 27;58(2):155-70. Transplantation. 1994. PMID: 7518974 Clinical Trial.

4

Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.

Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P. Platz KP, et al. Transplantation. 1994 Jul 27;58(2):170-8. Transplantation. 1994. PMID: 7518975 Clinical Trial.

5

Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease.

Mueller AR, Platz KP, Christe W, Bechstein WO, Blumhardt G, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplant Proc. 1994 Dec;26(6):3131-2. Transplant Proc. 1994. PMID: 7527951 Clinical Trial. No abstract available.

6

Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients.

Platz KP, Mueller AR, Bechstein WO, Blumhardt G, Neuhaus P. Platz KP, et al. Transplant Proc. 1994 Dec;26(6):3133-4. Transplant Proc. 1994. PMID: 7527952 Clinical Trial. No abstract available.

7

Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.

Mueller AR, Platz KP, Bechstein WO, Blumhardt G, Lobeck H, Hop U, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplant Proc. 1994 Dec;26(6):3637-9. Transplant Proc. 1994. PMID: 7527984 No abstract available.

8

Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.

Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M, et al. Neuhaus P, et al. Among authors: platz kp. Transplantation. 1995 Jan 15;59(1):31-40. doi: 10.1097/00007890-199501150-00007. Transplantation. 1995. PMID: 7530868 Clinical Trial.

9

OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.

Platz KP, Mueller AR, Zytowski M, Bechstein WO, Blumhardt G, Lobeck H, Neuhaus P. Platz KP, et al. Transplant Proc. 1995 Feb;27(1):1111-3. Transplant Proc. 1995. PMID: 7533357 Clinical Trial. No abstract available.

10

The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.

Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplant Proc. 1995 Feb;27(1):1117-20. Transplant Proc. 1995. PMID: 7533359 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters